APYX EBITDA | Apyx Medical Corp

Apyx Medical Corp (APYX) EBITDA

2026-06-30: Basis Reported; EBITDA -$1.61M*; Operating income -$1.81M; Depreciation and amortization $196.00K*.
2026-03-31: Basis Reported; EBITDA -$709,000.00; Operating income (m); Depreciation and amortization (m).
2025-12-31: Basis Reported; EBITDA $232,000.00; Operating income (m); Depreciation and amortization (m).
2025-09-30: Basis Reported; EBITDA -$668.00K*; Operating income -$832.00K; Depreciation and amortization $164.00K*.

Complete source-backed ebitda history.

Available history: 2009-12-31 to 2026-03-31
Data captured: 2026-09-04

Historical EBITDA

EBITDA 3 month

Date	Basis	EBITDA	Operating income	Depreciation and amortization	Revenue	EBITDA margin	Capital spending	Operating cash flow	Cost of products and services	Research and development	Selling, general and administration	Income tax expense / benefit
2026-06-30	Reported	-$1.61M*	-$1.81M	$196.00K*	$13.88M	-11.60%*	$66.00K*	-$3.49M*	$5.01M	$793.00K	$5.29M	$124.00K
2026-03-31	Reported	-$709,000.00	(m)	(m)	(m)	-5.68%	$60.00K	-$572.00K	$4.57M	$765.00K	$3.58M	$143.00K
2025-12-31	Reported	$232,000.00	(m)	(m)	(m)	1.21%	(m)	(m)	(m)	(m)	(m)	(m)
2025-09-30	Reported	-$668.00K*	-$832.00K	$164.00K*	$12.88M	-5.19%*	$519.00K*	-$3.54M*	$4.58M	$801.00K	$3.66M	$78.00K
2025-06-30	Reported	-$2.44M*	-$2.57M	$132.00K*	$11.37M	-21.47%*	$265.00K*	-$1.23M*	$4.29M	$824.00K	$4.26M	$49.00K
2025-03-31	Reported	-$2.91M	(m)	(m)	(m)	-30.89%	$55.00K	-$702.00K	$3.77M	$804.00K	$3.47M	$49.00K
2024-12-31	Reported	-$2.91M	(m)	(m)	(m)	-20.43%	(m)	(m)	(m)	(m)	(m)	(m)
2024-09-30	Reported	-$3.49M*	-$3.63M	$144.00K*	$11.49M	-30.39%*	$153.00K*	-$4.44M*	$4.53M	$1.14M	$4.29M	$60.00K
2024-06-30	Reported	-$5.39M*	-$5.55M	$156.00K*	$12.15M	-44.37%*	$289.00K*	-$4.33M*	$4.66M	$1.42M	$4.84M	$50.00K
2024-03-31	Reported	-$6.46M	(m)	(m)	(m)	-63.04%	$35.00K	-$6.34M	$4.29M	$1.40M	$4.90M	$53.00K
2023-12-31	Reported	-$5.62M	(m)	(m)	(m)	-38.36%	(m)	(m)	(m)	(m)	(m)	(m)
2023-09-30	Reported	-$4.45M*	-$4.64M	$186.00K*	$11.98M	-37.17%*	$174.00K*	$3.70M*	$4.00M	$1.41M	$4.84M	-$318.00K
2023-06-30	Reported	-$1.08M*	-$1.24M	$151.00K*	$13.57M	-7.99%*	$156.00K*	-$4.85M*	$4.29M	$1.36M	$5.38M	$66.00K
2023-03-31	Reported	-$5.41M	(m)	(m)	(m)	-44.54%	$110.00K	-$1.88M	$4.57M	$1.27M	$5.25M	-$2.27M
2022-12-31	Reported	-$5.73M	(m)	(m)	(m)	-45.44%	(m)	(m)	(m)	(m)	(m)	(m)
2022-09-30	Reported	-$5.57M*	-$5.78M	$216.00K*	$9.11M	-61.07%*	$188.00K*	-$5.36M*	$3.36M	$1.06M	$4.67M	$50.00K
2022-06-30	Reported	-$5.73M*	-$5.98M	$247.00K*	$10.29M	-55.66%*	$401.00K*	-$5.87M*	$3.38M	$1.07M	$4.54M	$96.00K
2022-03-31	Reported	-$5.65M	(m)	(m)	(m)	-45.19%	$279.00K	-$4.52M	$4.27M	$1.16M	$5.46M	$70.00K
2021-12-31	Reported	-$1.46M	(m)	(m)	(m)	-8.70%	(m)	(m)	(m)	(m)	(m)	(m)
2021-09-30	Reported	-$3.73M*	-$3.97M	$234.00K*	$11.83M	-31.56%*	$170.00K*	-$3.60M*	$3.77M	$1.18M	$4.61M	$73.00K
2021-06-30	Reported	-$3.83M*	-$4.04M	$213.00K*	$11.22M	-34.12%*	$29.00K*	-$5.01M*	$3.69M	$1.08M	$4.26M	$107.00K
2021-03-31	Reported	-$4.52M	(m)	(m)	(m)	-52.30%	$192.00K	-$2.05M	$2.78M	$1.11M	$3.72M	$66.00K
2020-12-31	Reported	-$1.83M	(m)	(m)	(m)	-15.95%	(m)	(m)	(m)	(m)	(m)	(m)
2020-09-30	Reported	-$4.15M*	-$4.37M	$223.00K*	$6.95M	-59.65%*	$9.00K*	-$2.62M*	$2.23M	$1.05M	$2.71M	-$715.00K
2020-06-30	Reported	-$5.94M*	-$6.17M	$225.00K*	$4.30M	-138.31%*	$94.00K*	-$5.03M*	$2.20M	$975.00K	$2.19M	-$1.49M
2020-03-31	Reported	-$7.28M	(m)	(m)	(m)	-145.65%	$90.00K	-$7.41M	$2.01M	$980.00K	$3.80M	-$4.91M
2019-12-31	Reported	-$5.72M	(m)	(m)	(m)	-68.21%	(m)	(m)	(m)	(m)	(m)	(m)
2019-09-30	Reported	-$4.56M*	-$4.76M	$194.00K*	$7.58M	-60.22%*	$558.00K*	-$4.55M*	$2.28M	$1.02M	$3.84M	$171.00K
2019-06-30	Reported	-$4.30M*	-$4.42M	$122.00K*	$6.65M	-64.67%*	$401.00K*	-$5.59M*	$1.98M	$888.00K	$3.04M	$76.00K
2019-03-31	Reported	-$5.54M	(m)	(m)	(m)	-98.35%	$117.00K	-$5.09M	$2.07M	$730.00K	$2.96M	$6.00K
2018-12-31	Reported	-$5.6M	(m)	(m)	(m)	-95.72%	(m)	(m)	(m)	(m)	(m)	(m)
2018-09-30	Reported	-$2.74M	(m)	(m)	(m)	-74.56%	-$129.00K*	-$1.15M*	$1.15M	$613.00K	$1.90M	-$2.41M
2018-06-30	Reported	-$2.76M	(m)	(m)	(m)	-74.80%	$193.00K*	-$573.00K*	$1.15M	$763.00K	$2.21M	$13.00K
2018-03-31	Reported	-$2.52M	(m)	(m)	(m)	-74.21%	$139.00K	-$1.11M	$1.19M	$514.00K	$2.11M	$11.00K
2017-12-31	Reported	-$3.07M	(m)	(m)	(m)	-83.87%	(m)	(m)	(m)	(m)	(m)	(m)
2017-09-30	Reported	-$2.66M	(m)	(m)	(m)	-100.41%	$280.00K*	-$541.00K*	$738.00K	$487.00K	$2.01M	$6.00K
2017-06-30	Reported	-$1.13M	(m)	(m)	(m)	-11.51%	$80.00K*	-$1.08M*	$4.76M	$696.00K	$2.93M	$4.00K
2017-03-31	Reported	-$1.56M	(m)	(m)	(m)	-18.58%	$71.00K	-$2.82M	$4.16M	$709.00K	$2.40M	$5.00K
2016-12-31	Reported	-$8.47M	(m)	(m)	(m)	46.23%	(m)	(m)	(m)	(m)	(m)	(m)
2016-09-30	Reported	-$44,000.00	(m)	(m)	(m)	-0.44%	$141.00K*	$87.00K*	$5.00M	$681.00K	$2.14M	$0.00
2016-06-30	Reported	-$337,000.00	(m)	(m)	(m)	-3.63%	$20.00K*	-$113.00K*	$4.59M	$592.00K	$2.02M	$0.00
2016-03-31	Reported	-$1.81M	(m)	(m)	(m)	-23.29%	$21.00K	-$2.27M	$4.45M	$668.00K	$2.19M	$0.00
2015-12-31	Reported	-$1.17M	(m)	(m)	(m)	-14.11%	(m)	(m)	(m)	(m)	(m)	(m)
2015-09-30	Reported	-$1.60M*	-$1.81M	$210.00K*	(m)	(m)	$142.00K*	-$644.00K*	$4.59M	$583.00K	$2.10M	$0.00*
2015-06-30	Reported	-$1.34M*	-$1.55M	$204.00K*	(m)	(m)	$208.00K*	-$2.33M*	$4.13M	$505.00K	$2.00M	$0.00*
2015-03-31	Reported	-$2.06M	(m)	(m)	(m)	-33.53%	$254.00K	-$1.79M	$3.45M	$446.00K	$2.22M	$8.00K
2014-12-31	Reported	-$1.57M	(m)	(m)	(m)	-21.07%	(m)	(m)	(m)	(m)	(m)	(m)
2014-09-30	Reported	-$2.16M*	-$2.37M	$203.00K*	(m)	(m)	$155.00K*	$698.00K*	$4.87M	$368.00K	$2.12M	-$1.35M
2014-06-30	Reported	-$1.52M*	-$1.75M	$221.00K*	(m)	(m)	$89.00K*	-$264.00K*	$5.07M	$318.00K	$1.60M	-$583.00K
2014-03-31	Reported	$290,000.00	(m)	(m)	(m)	4.47%	$75.00K	-$1.05M	$3.73M	$332.00K	$1.20M	$38.00K
2013-12-31	Reported	-$669,000.00	(m)	(m)	(m)	-10.92%	(m)	(m)	(m)	(m)	(m)	(m)
2013-09-30	Reported	-$271.00K*	-$475.00K	$204.00K*	(m)	(m)	$124.00K*	$78.00K*	$3.54M	$291.00K	$1.17M	-$175.00K
2013-06-30	Reported	-$1.45M*	-$1.65M	$204.00K*	(m)	(m)	$162.00K*	-$1.01M*	$3.81M	$314.00K	$2.18M	-$554.00K
2013-03-31	Reported	-$453,000.00	(m)	(m)	(m)	-7.95%	$131.00K	-$253.00K	$3.54M	$333.00K	$1.21M	-$345.00K
2012-12-31	Reported	$230,000.00	(m)	(m)	(m)	3.37%	(m)	(m)	(m)	(m)	(m)	(m)
2012-09-30	Reported	$482.00K*	$282.00K	$200.00K*	(m)	(m)	$162.00K*	-$300.00K*	$3.78M	$322.00K	$1.10M	$96.00K
2012-06-30	Reported	$456.00K*	$240.00K	$216.00K*	(m)	(m)	$44.00K*	$940.00K*	$4.58M	$349.00K	$1.12M	$74.00K
2012-03-31	Reported	$620,000.00	(m)	(m)	(m)	9.21%	$243.00K	-$486.00K	$3.94M	$298.00K	$1.02M	$134.00K
2011-12-31	Reported	-$1.33M	(m)	(m)	(m)	-21.51%	(m)	(m)	(m)	(m)	(m)	(m)
2011-09-30	Reported	$472.00K*	$248.00K	$224.00K*	(m)	(m)	$198.00K*	-$72.00K*	$3.65M	$288.00K	$996.00K	$76.00K
2011-06-30	Reported	$773.00K*	$549.00K	$224.00K*	(m)	(m)	$186.00K*	$1.48M*	$3.80M	$289.00K	$1.13M	$181.00K
2011-03-31	Reported	$814,000.00	(m)	(m)	(m)	13.23%	$75.00K	$737.00K	$3.72M	$347.00K	$1.10M	$182.00K
2010-12-31	Reported	-$1.58M	(m)	(m)	(m)	-25.33%	(m)	(m)	(m)	(m)	(m)	(m)
2010-09-30	Reported	$146.00K*	-$115.00K	$261.00K*	(m)	(m)	$63.00K*	-$621.00K*	$3.80M	$442.00K	$1.04M	-$5.00K
2010-06-30	Reported	(m)	-$791.00K	(m)	(m)	(m)	(m)	(m)	$3.58M	$525.00K	$1.38M	$297.00K

EBITDA 12 month

Date	Basis	EBITDA	Operating income	Depreciation and amortization	Revenue	EBITDA margin	Capital spending	Operating cash flow	Cost of products and services	Research and development	Selling, general and administration	Income tax expense / benefit
2025-12-31	Reported	-$5.79M	(m)	(m)	(m)	-10.96%	$1.11M	-$8.00M	$19.80M	$3.37M	$15.80M	$270.00K
2024-12-31	Reported	-$18.25M	(m)	(m)	(m)	-37.93%	$722.00K	-$18.05M	$18.74M	$5.08M	$18.86M	$252.00K
2023-12-31	Reported	-$16.57M	(m)	(m)	(m)	-31.65%	$533.00K	-$5.25M	$18.59M	$5.44M	$22.20M	-$2.43M
2022-12-31	Reported	-$22.67M	(m)	(m)	(m)	-50.94%	$1.01M	-$20.28M	$15.38M	$4.54M	$20.48M	$367.00K
2021-12-31	Reported	-$13.55M	(m)	(m)	(m)	-27.92%	$723.00K	-$10.45M	$14.92M	$4.32M	$18.62M	$380.00K
2020-12-31	Reported	-$19.2M	(m)	(m)	(m)	-69.27%	$581.00K	-$16.07M	$10.21M	$3.92M	$11.69M	-$7.50M
2019-12-31	Reported	-$20.12M	(m)	(m)	(m)	-71.24%	$1.30M	-$18.48M	$9.14M	$3.73M	$13.70M	-$130.00K
2018-12-31	Reported	-$13.61M	(m)	(m)	(m)	-81.95%	$363.00K	-$20.88M	$5.78M	$2.55M	$9.41M	-$3.91M
2017-12-31	Reported	-$13.19M	(m)	(m)	(m)	-128.87%	$624.00K	-$3.70M	$3.28M	$1.94M	$8.69M	-$156.00K
2016-12-31	Reported	-$10.66M	(m)	(m)	(m)	-120.85%	$286.00K	-$2.84M	$3.70M	$1.03M	$6.18M	$64.00K
2015-12-31	Reported	-$6.17M	(m)	(m)	(m)	-20.91%	$421.00K	-$5.79M	$16.96M	$2.16M	$8.42M	$25.00K
2014-12-31	Reported	-$4.97M	(m)	(m)	(m)	-17.97%	$630.00K	-$417.00K	$18.69M	$1.42M	$6.69M	$4.00M
2013-12-31	Reported	-$2.84M	(m)	(m)	(m)	-12.00%	$588.00K	-$2.54M	$14.46M	$1.26M	$5.78M	-$1.61M
2012-12-31	Reported	$1.79M	(m)	(m)	(m)	6.46%	$753.00K	$165.00K	$16.34M	$1.33M	$4.34M	$217.00K
2011-12-31	Reported	$735,000.00	(m)	(m)	(m)	2.89%	$542.00K	$1.90M	$14.68M	$1.20M	$4.35M	$77.00K
2010-12-31	Reported	-$2.02M	(m)	(m)	(m)	-8.33%	$201.00K	-$526.00K	$14.24M	$1.85M	$4.89M	-$927.00K
2009-12-31	Reported	$1.49M	(m)	(m)	(m)	5.54%	$2.46M	-$97.00K	$15.10M	$2.08M	$4.66M	$67.00K

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
Microbot Medical Inc. (MBOT)		$0.089B	-7.97
KORU Medical Systems, Inc. (KRMD)	United States	$0.151B	-106.78
LENSAR, Inc. (LNSR)	United States	$0.087B	2.02
SkinHealth Systems Inc. (SKIN)	United States	$0.086B	-3.17
Pulmonx Corp (LUNG)	United States	$0.082B	-1.16
RenovoRx, Inc. (RNXT)	United States	$0.076B	-3.62
FRACTYL HEALTH, INC. (GUTS)	United States	$0.075B	-1.18
Lucid Diagnostics Inc. (LUCD)	United States	$0.170B
CVRx, Inc. (CVRX)	United States	$0.067B	-2.62
DarioHealth Corp. (DRIO)		$0.066B	-1.39